Page 854 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 854

812                                    RESISTANCE AUX ANTTTUMORAUX


             BIGNAMI M. et al., Unmasking a killer: DNA O-méthylguanine and the cytotoxicity of
               methylating agents, Mutation Research, 2000, 462, 71-82.
                                                           6
             GRIFFIN R.J. et al., Resistance-modifying agents. 8. Inhibition of 0 -alkylguanine-DNA
               alkyltransferase by O-alkenyl-, O-cycloalkenyl- and O-(2-0x0alkyl)guanines and
                                                    6
               potentiation of temozolomide cytotoxicity in vitro by 0 -(1-cyclopentenylmethyl)gua-
               nine, J. Med. Chem, 2000, 43, 4071-4083.
                            6
              PEGG A., Repair of 0 -alkylguanine by alkyltransferases, Mutation Research, 2000, 462,
               83-100.
                                                   6
              LUU K.X. et al., Repair of oligodeoxyribonucleotides by 0 -Alkylguanine-DNA Alkyltrans-
               ferase, Biochemistry, 2002, 41, 8689-8697.
              BER
              ROBERTSON K.A., Altered expression of Ape1/ref-1 in germ cell tumors and overexpres-
                sion in NT2 cells confers resistance to bleomycin and radiation, Cancer Research,
                2001, 61, 2220-2225.
              BUDWORTH H. et al., Repair of clustered DNA lesions, J. Biol. Chem., 2002, 277, 24,
                21300-21305.
              ROTH R.B., SAMSON L.D., 3-Methyladenine DNA glycosylase-deficient Aag Null mice
                display unexpected bone marrow alkylation resistance, Cancer Research, 2002, 62,
                656-660.
               PARK S.Y. et al., X-ray repair cross-complementing gene I protein plays an important
                role in camptothecin resistance, Cancer Research, 2002, 62, 459-465.

               MMR
               FINK D. et al., The role of DNA mismatch repair in drug resistance, Clin. CancerResearch,
                 1998, 4, 2-6.
               TAVERNA P. et al., Characterization of MLH1 and MSH2 DNA mismatch repair proteins
                 in cell lines of the NCI anticancer drug screen, Cancer Chemother Pharmacol., 2000,
                 46, 507-516.
               JACOB S., PRAZ F., DNA mismatch repair defects: role in colorectal carcinogenesis,
                 Biochimie, 2002, 84, 27-47.

               RECOMBINAISON
               KARRAN P., DNA double strand break repair in mammalian cells, Current Opinion in
                 Genetics & Development, 2000, 10, 144-150.
               WANG Z.M. et al., ln vitro evidence for homologous recombinational repair in resistance
                 to melphalan, J. Nat. Cancer Inst., 2001, 93, 1473-1478.
               SAINTIGNY Y. et al., Characterization of homologous recombination induced by réplica-
                 tion inhibition in mammalian cells, EMBO J., 2001, 20, 3861-3870.
               Site: http://www.biochimieep7.jussieu.fr
               Site : http://www.curie.u-psud.fr/U350
               PARP
               GRIFFIN R.J. et al., The role of inhibitors of poly(ADP-ribose) polymerase as resistance-
                modifying agents in cancer therapy, Biochimie, 1995, 77, 408-422.
   849   850   851   852   853   854   855   856   857   858   859